NAPSA and lung adenocarcinoma: Therefore, some authors have suggested a combined analysis using both TTF-1 and Napsin A, reaching a sensitivity of 84.9% and a specificity of 99.1% for the distinction of lung adenocarcinomas from their counterparts in other anatomical sites [33].